ArticleBMC psychiatry2026
Prevalence and cognitive correlates of sleep problems in Chinese patients with first-episode drug-naïve schizophrenia.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleep problems (SPs) frequently occur in patients with schizophrenia patients experiencing cognitive impairments. Thus, this study aimed to investigate the association between SPs and first-episode drug-naive schizophrenia (FDS), and to examine the impact of SPs on their cognitive function.
methodsIn this cross-sectional study, we enrolled 291 FDS patients (non-SPs/SPs = 197/94) and 685 subjects from the general population (GP, non-SPs/SPs = 577/108) according to the DSM-IV and Pittsburgh Sleep Quality Index (PSQI) grouping. Cognition and sleep quality of subjects were assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the PSQI, respectively.
resultsCompared to GP subjects, patients with FDS had a significantly higher prevalence of SPs (15.77% versus 32.30%, OR = 2.55, p < 0.001) and a significantly higher total score of PSQI (p < 0.001). After adjusting for covariates, the visuospatial/constructional score of SPs was significantly lower than that of non-SPs in patients with FDS (p < 0.05), and all RBANS scores of patients with FDS were significantly lower than those of GP subjects, with or without SPs (p < 0.001), excepted for the visuospatial/constructional score. Pearson correlation and linear regression analyses showed a negative association between the total PSQI score and the visuospatial/constructional score in patients with FDS (p < 0.05).
conclusionsOur findings confirm a significant association between SPs and FDS. Notably, the presence of SPs in patients with FDS is linked to more severe visuospatial/constructional impairments, suggesting that targeting sleep quality might help mitigate this specific cognitive impairment. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.